Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Bogenschutz

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Alcoholism, Clinical and Experimental Research|October 27, 2007
12-step approaches for the dually diagnosed: mechanisms of changeMichael P Bogenschutz
Current Drug Abuse Reviews|May 1, 2013
Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybinMichael P Bogenschutz
The American Journal of Drug and Alcohol Abuse|August 26, 2016
It's time to take psilocybin seriously as a possible treatment for substance use disordersMichael P Bogenschutz
Addiction (Abingdon, England)|August 12, 2024
A clinical research perspective on the regulation of medical and non-medical use of psychedelic drugsMichael P Bogenschutz
Community Mental Health Journal|June 4, 2005
Specialized 12-step programs and 12-step facilitation for the dually diagnosedMichael P Bogenschutz
Recent Developments in Alcoholism : an Official Publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism|January 1, 2009
Individual and contextual factors that influence AA affiliation and outcomesMichael P Bogenschutz
The American Journal of Psychiatry|January 1, 2024
Pharmacological and Nonpharmacological Components of Psychedelic Treatments: The Whole is Not the Sum of the PartsMichael P Bogenschutz
Journal of Psychoactive Drugs|May 22, 2009
Pharmacological research on addictions: a framework for ethical and policy considerationsCynthia Geppert, Michael P Bogenschutz
Current Topics in Behavioral Neurosciences|May 18, 2017
Therapeutic Applications of Classic HallucinogensMichael P Bogenschutz, Stephen Ross
The Journal of Clinical Psychiatry|January 28, 2004
Olanzapine versus placebo in the treatment of borderline personality disorderMichael P Bogenschutz, H George Nurnberg
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Alcoholism, Clinical and Experimental Research|October 27, 2007
12-step approaches for the dually diagnosed: mechanisms of changeMichael P Bogenschutz
Current Drug Abuse Reviews|May 1, 2013
Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybinMichael P Bogenschutz
The American Journal of Drug and Alcohol Abuse|August 26, 2016
It's time to take psilocybin seriously as a possible treatment for substance use disordersMichael P Bogenschutz
Addiction (Abingdon, England)|August 12, 2024
A clinical research perspective on the regulation of medical and non-medical use of psychedelic drugsMichael P Bogenschutz
Community Mental Health Journal|June 4, 2005
Specialized 12-step programs and 12-step facilitation for the dually diagnosedMichael P Bogenschutz
Recent Developments in Alcoholism : an Official Publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism|January 1, 2009
Individual and contextual factors that influence AA affiliation and outcomesMichael P Bogenschutz
The American Journal of Psychiatry|January 1, 2024
Pharmacological and Nonpharmacological Components of Psychedelic Treatments: The Whole is Not the Sum of the PartsMichael P Bogenschutz
Journal of Psychoactive Drugs|May 22, 2009
Pharmacological research on addictions: a framework for ethical and policy considerationsCynthia Geppert, Michael P Bogenschutz
Current Topics in Behavioral Neurosciences|May 18, 2017
Therapeutic Applications of Classic HallucinogensMichael P Bogenschutz, Stephen Ross
The Journal of Clinical Psychiatry|January 28, 2004
Olanzapine versus placebo in the treatment of borderline personality disorderMichael P Bogenschutz, H George Nurnberg
Pageof 7